If AmSurg Reports, Will Anyone Care?

• Posted by Danny
• on October 24th, 2012

Probably not, but that’s cool. We didn’t care much about ‘em either until recently.

 

Based out of Nashville, AmSurg ($AMSG) specializes in developing and operating ambulatory surgery centers across the U.S. They reported Q3 earnings last night that were basically in-line, and it looked something like this:

• Revenue +16% YoY to $226 mil
• Net income +13% YoY to $53.8 mil
• Same-center revs +2% YoY

• YTD revenue +23% YoY
• YTD net income +27% YoY

…and for the ever important guidance, the CEO had this to say:

• Revenues in a range of $915 million to $925 million for 2012 compared with the previous range of $905 million to $925 million.
• Same-center revenue increase of 3% for 2012, up from the prior range of 2% to 3%.

Ranked #23 in the BeanScreen this month, we rolled the dice ahead of earnings and started a position last week at $27. Guess we’ll find out today if that was a good move or not…or maybe the market could care less.

 

sources:  Earnings: AmSurg profits jump 13 percent – Nashville Business Journal

AmSurg.com

 

 

The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.

blog comments powered by Disqus